Ozempic, the once-a-week injection, will be available only on a doctor's prescription. (Photo: Pxhere) Show Quick Read Summary is AI Generated. Newsroom Reviewed

India's drug regulator Central Drugs Standard Control Organisation (CDSCO) has approved Ozempic (semaglutide injection) manufactured by Danish pharma company Novo Nordisk for use in adults with type 2 diabetes. According to sources, Ozempic, the once-a-week injection, will be available only on a doctor's prescription.

"Semaglutide Injection (Ozempic@) is indicated for the treatment of adults with Insufficiently Controlled Type 2 Diabetes Mellitus as an adjunct to Diet and Exercise," the approval by CDSCO said on Sept. 26, 2025.

What is Ozempic

Ozempic is the brand name for the injectable drug semaglutide. It belongs to a

See Full Page